Verition Fund Management
LLY icon

Verition Fund Management’s Eli Lilly LLY Stock Holding History

Verition Fund Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.77M Sell
3,008
-2,185
-42% -$2.22M 0.02% 858
2025
Q4 		$5.58M Sell
5,193
-233,084
-98% -$223M 0.02% 791
2025
Q3 		$182M Buy
238,277
+225,968
+1,836% +$168M 0.75% 9
2025
Q2 		$9.6M Sell
12,309
-1,381
-10% -$1.07M 0.04% 545
2025
Q1 		$11.3M Sell
13,690
-204
-1% -$170K 0.05% 410
2024
Q4 		$10.7M Buy
13,894
+3,903
+39% +$3.23M 0.04% 490
2024
Q3 		$8.85M Sell
9,991
-883
-8% -$794K 0.04% 463
2024
Q2 		$9.85M Sell
10,874
-1,499
-12% -$1.2M 0.05% 353
2024
Q1 		$9.63M Sell
12,373
-167,467
-93% -$119M 0.07% 346
2023
Q4 		$105M Buy
179,840
+167,810
+1,395% +$98M 0.82% 10
2023
Q3 		$6.46M Sell
12,030
-4,277
-26% -$2.2M 0.08% 344
2023
Q2 		$7.65M Sell
16,307
-19,429
-54% -$8.15M 0.1% 268
2023
Q1 		$12.3M Buy
35,736
+32,227
+918% +$10.9M 0.17% 154
2022
Q4 		$1.28M Sell
3,509
-4,992
-59% -$1.77M 0.02% 808
2022
Q3 		$2.75M Buy
8,501
+4,521
+114% +$1.43M 0.03% 714
2022
Q2 		$1.29M Buy
3,980
+2,342
+143% +$703K 0.03% 897
2022
Q1 		$469K Sell
1,638
-574
-26% -$148K 0.01% 1934
2021
Q4 		$611K Sell
2,212
-825
-27% -$209K ﹤0.01% 1592
2021
Q3 		$702K Buy
+3,037
New +$750K 0.01% 1081
2021
Q1 		– Sell
-47,001
Closed -$7.94M – 1670
2020
Q4 		$7.94M Buy
47,001
+44,197
+1,576% +$6.6M 0.07% 157
2020
Q3 		$415K Buy
+2,804
New +$434K 0.01% 648
2020
Q1 		– Sell
-28,583
Closed -$3.76M – 853
2019
Q4 		$3.76M Buy
+28,583
New +$3.31M 0.07% 178
2019
Q3 		– Sell
-14,168
Closed -$1.57M – 1203
2019
Q2 		$1.57M Buy
+14,168
New +$1.67M 0.04% 297
2018
Q4 		– Sell
-115,029
Closed -$12.3M – 1077
2018
Q3 		$12.3M Buy
115,029
+104,256
+968% +$10.4M 0.44% 28
2018
Q2 		$919K Buy
10,773
+7,815
+264% +$642K 0.06% 445
2018
Q1 		$229K Sell
2,958
-25,932
-90% -$2.09M 0.02% 942
2017
Q4 		$2.44M Buy
28,890
+26,457
+1,087% +$2.25M 0.23% 78
2017
Q3 		$208K Sell
2,433
-4,700
-66% -$385K 0.02% 1051
2017
Q2 		$587K Buy
7,133
+1,987
+39% +$162K 0.06% 362
2017
Q1 		$433K Buy
5,146
+1,855
+56% +$149K 0.04% 647
2016
Q4 		$242K Sell
3,291
-1,523
-32% -$113K 0.02% 948
2016
Q3 		$386K Sell
4,814
-1,894
-28% -$152K 0.04% 628
2016
Q2 		$528K Buy
+6,708
New +$505K 0.07% 363
2016
Q1 		– Sell
-11,244
Closed -$947K – 763
2015
Q4 		$947K Buy
+11,244
New +$933K 0.18% 111
2015
Q2 		– Sell
-3,131
Closed -$227K – 672
2015
Q1 		$227K Sell
3,131
-405
-11% -$28.8K 0.03% 284
2014
Q4 		$244K Sell
3,536
-3,640
-51% -$246K 0.05% 185
2014
Q3 		$465K Sell
7,176
-22
-0.3% -$1.39K 0.07% 258
2014
Q2 		$447K Buy
7,198
+488
+7% +$29.1K 0.05% 284
2014
Q1 		$395K Buy
6,710
+800
+14% +$44.6K 0.06% 221
2013
Q4 		$301K Buy
+5,910
New +$296K 0.05% 271
2013
Q3 		– Sell
-6,941
Closed -$341K – 630
2013
Q2 		$341K Buy
+6,941
New +$378K 0.06% 314

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Verition Fund Management's LLY Position: Q1 2026 in Review

Verition Fund Management reduced its Eli Lilly (LLY) stake by 42% in Q1 2026, selling an estimated $2.22M and leaving 3,008 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #858.

Verition Fund Management first reported a position in LLY in Q2 2013 and has held it in 41 quarters since. The position peaked at $182M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Verition Fund Management held 3,008 shares of Eli Lilly worth $2.77M as of Q1 2026.
  • Verition Fund Management sold 2,185 Eli Lilly shares in Q1 2026, an estimated $2.22M.
  • Eli Lilly made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #858 holding.
  • Verition Fund Management first reported a position in Eli Lilly in Q2 2013 and has held it in 41 quarters since.
  • Verition Fund Management's Eli Lilly position peaked at $182M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.